China headquartered life sciences company Fapon has announced the launch of its latest chemiluminescence immunoassay system Shine i8000/9000 to global markets at the 2023 American Association of Clinical Chemistry (AACC) Scientific Meeting and Clinical Lab Expo, being held from July 25 to 27.

The high-speed and fully automated analyser has an ultra-high throughput of 900 tests per hour, and will empower its partners to build premium clinical diagnostic solutions.

According to Kevin Liu, Global Sales Director of Fapon, “The Shine i8000/9000 Chemiluminescence Immunoassay Analyzsr boasts an extraordinary testing performance and tackles the increasing needs of laboratories."

To meet the urgent need for high-throughput testing instruments, the Shine i8000/9000 is designed to provide efficient and intelligent solutions for medium to large-sized laboratories, including medical centres, third-party medical laboratories, large-scale physical examination centers, and animal disease control centres.

At the expo, Fapon is also exhibiting its innovative solution on drug discovery and development. Fapon Biopharma, a subsidiary of Fapon, has developed a fully-integrated platform that includes programmes from discovery to clinical research stages for novel biological products.